Clinical Trial: A Study on the Effects and Efficacy of Brainspotting Psychotherapy for Cancer Patients and Patients with Depression (Japan)

Tokyo, Dec. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060204) titled 'A Study on the Effects and Efficacy of Brainspotting Psychotherapy for Cancer Patients and Patients with Depression' on Dec. 26.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Non-randomized Blinding - Open -no one is blinded Control - Dose comparison

Primary Sponsor: Institute - Sapporo Medical University

Condition: Condition - Cancer,Depression Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - Regarding the psychological distress experienced by cancer patients, including anxiety and depression, this study views it as encompassing the pathology of traumatic experiences. It aims to verify the efficacy of Brainspotting, a recently developed psychotherapy addressing traumatic memories, to maintain and enhance the mental health and improve the quality of life (QOL) of cancer patients and those presenting with depression or depressive states. Concurrently, we will analyze fluctuations in various psychological and biological factors correlated with these effects, attempting to establish psychological and biological indicators substantiating its efficacy. Basic objectives2 - Safety,Efficacy

Intervention: Interventions/Control_1 - Cancer Patient Interventions/Control_2 - Depression Patient

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - (1) Patients aged 18 years or older, regardless of gender (2) Individuals experiencing anxiety, depression, or other mental health difficulties related to cancer or mood disorders, who are willing and able to attend outpatient treatment aimed at symptom improvement (3) Individuals who understand the purpose and procedures of this study and who provide written informed consent to participate voluntarily Key exclusion criteria - Those deemed inappropriate by the attending physician's judgment Target Size - 40

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 12 Month 26 Day Anticipated trial start date - 2026 Year 01 Month 15 Day Last follow-up date - 2028 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068858

Disclaimer: Curated by HT Syndication.